| P50 | author | Krishna M Panchalingam | Q58898505 |
| P2093 | author name string | Sunghoon Jung | |
| | Leo A Behie | |
| | Lawrence Rosenberg | |
| | Reynold D Wuerth | |
| P2860 | cites work | Expansion and hepatic differentiation of rat multipotent adult progenitor cells in microcarrier suspension culture | Q39669482 |
| | Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial | Q39955188 |
| | Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study | Q40321403 |
| | Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells | Q42444844 |
| | "Humanized" stem cell culture techniques: the animal serum controversy | Q42735346 |
| | Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells | Q42978697 |
| | Cell culture medium composition and translational adult bone marrow-derived stem cell research | Q43219866 |
| | Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. | Q43222889 |
| | Expansion of human mesenchymal stromal cells on microcarriers: growth and metabolism | Q43258428 |
| | "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). | Q43897756 |
| | Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications | Q43898390 |
| | Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy | Q44878272 |
| | Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. | Q45501605 |
| | Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate | Q45863683 |
| | Modeled microgravity inhibits osteogenic differentiation of human mesenchymal stem cells and increases adipogenesis | Q46285888 |
| | Comparison of human serum with fetal bovine serum for expansion and differentiation of human synovial MSC: potential feasibility for clinical applications | Q46421017 |
| | Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. | Q46488249 |
| | Expansion of mesenchymal stem cells using a microcarrier-based cultivation system: growth and metabolism | Q46695495 |
| | Defining the risks of mesenchymal stromal cell therapy | Q47584701 |
| | A microcarrier-based cultivation system for expansion of primary mesenchymal stem cells. | Q50472131 |
| | Ex vivo expansion of rat bone marrow mesenchymal stromal cells on microcarrier beads in spin culture. | Q50689304 |
| | Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. | Q50707616 |
| | Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. | Q50942078 |
| | Collagenous microbeads as a scaffold for tissue engineering with adipose-derived stem cells. | Q50955509 |
| | Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. | Q51018136 |
| | Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. | Q51116689 |
| | Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues. | Q51141337 |
| | Human autologous serum obtained using a completely closed bag system as a substitute for foetal calf serum in human mesenchymal stem cell cultures. | Q51225476 |
| | In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. | Q51378561 |
| | From stem cells to viable autologous semilunar heart valve. | Q51447883 |
| | Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow. | Q51757933 |
| | Bone formation by mesenchymal progenitor cells cultured on dense and microporous hydroxyapatite particles. | Q51786371 |
| | Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). | Q51953623 |
| | Expansion of Human Hematopoietic Cells from Umbilical Cord Blood Using Roller Bottles in CO2and CO2-Free Atmosphere | Q53301863 |
| | Influence of culture parameters on ear mesenchymal stem cells expanded on microcarriers. | Q53306427 |
| | Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. | Q53540450 |
| | Bioreactor development for stem cell expansion and controlled differentiation | Q24676967 |
| | Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 |
| | Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study | Q29617267 |
| | Mesenchymal stem cells reside in virtually all post-natal organs and tissues | Q29617740 |
| | Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6 | Q29620590 |
| | Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue | Q29620725 |
| | Low serum and serum-free culture of multipotential human adipose stem cells | Q30444668 |
| | Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. | Q31135210 |
| | Proliferation, activity, and osteogenic differentiation of bone marrow stromal cells cultured on calcium titanium phosphate microspheres | Q33208965 |
| | Aging of mesenchymal stem cell in vitro. | Q33236089 |
| | From microcarriers to hydrodynamics: introducing engineering science into animal cell culture | Q33255275 |
| | Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells | Q33307769 |
| | Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties | Q34068369 |
| | Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study | Q34132522 |
| | RhoA and cytoskeletal disruption mediate reduced osteoblastogenesis and enhanced adipogenesis of human mesenchymal stem cells in modeled microgravity | Q34312867 |
| | The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments | Q34686955 |
| | Fluid-mechanical damage of animal cells in bioreactors | Q35292164 |
| | Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions | Q35579672 |
| | Wharton's jelly-derived cells are a primitive stromal cell population | Q35849157 |
| | Bead-to-bead transfer of Vero cells in microcarrier culture | Q36254780 |
| | A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction | Q36634299 |
| | Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned med | Q36775037 |
| | Concise review: adipose tissue-derived stromal cells--basic and clinical implications for novel cell-based therapies | Q36786235 |
| | Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. | Q36874456 |
| | UC blood-derived mesenchymal stromal cells: an overview | Q36961702 |
| | Immunomodulation by mesenchymal stem cells and clinical experience | Q36975987 |
| | Functional Cells Cultured on Microcarriers for Use in Regenerative Medicine Research | Q37795961 |
| | Good manufacturing practices production of mesenchymal stem/stromal cells. | Q37804393 |
| | Stem cell cultivation in bioreactors | Q37897334 |
| | A novel serum-free medium for the expansion of human mesenchymal stem cells. | Q39448462 |
| | Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells | Q39647492 |
| P433 | issue | 2 | |
| P304 | page(s) | 106-120 | |
| P577 | publication date | 2012-03-01 | |
| P1433 | published in | Biotechnology and Applied Biochemistry | Q4915336 |
| P1476 | title | Large-scale production of human mesenchymal stem cells for clinical applications | |
| P478 | volume | 59 | |